Violet Medi-Pharma Private Limited

Violet Medi-Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74120MH2015PTC267648 Incorporated 21 August 2015 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹1.27 Cr
▼ 7.12% YoY
Net profit · FY 2022
₹54,750
Net margin 0.4%
EBITDA · FY 2022
₹1.04 Lakh
EBITDA margin 0.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Violet Medi-Pharma Private Limited

Data last updated:

Violet Medi-Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 August 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2015PTC267648. Its GSTIN is 27AAFCV2125H1ZG (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hitesh Sampat Ranawat and Sampat Surajmal Ranawat.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 57A Parin Villa D Daulat Nagar Main Road Borivali (East), Mumbai, Maharashtra, India – 400066.

As per the financials filed for FY 2022, the company reported a revenue of ₹1.27 Cr. For the same year it recorded a net profit of ₹54,750 (net margin 0.4%) and EBITDA of ₹1.04 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 57% over five years.

Court records list 1 case involving the company, including 1 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Violet Medi-Pharma Private Limited
CIN U74120MH2015PTC267648
Registration Number 267648
Incorporation Date 21 August 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    57A Parin Villa D Daulat Nagar Main Road Borivali (East), Mumbai, Maharashtra, India – 400066
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Violet Medi-Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Violet Medi-Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Violet Medi-Pharma Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Violet Medi-Pharma Private Limited

The main business activity of Violet Medi-Pharma is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Violet Medi-Pharma Private Limited FY 2022 filings available

Violet Medi-Pharma Private Limited reported revenue of ₹1.27 Cr for FY 2022.

Revenue · FY 2022
₹1.27 Cr
Net profit · FY 2022
₹54,750 margin 0.4%
EBITDA · FY 2022
₹1.04 Lakh margin 0.8%

Compounded Annual Growth Rate (CAGR) of Violet Medi-Pharma Private Limited

Revenue CAGR growth
3 years · compounded
▼ 18%
5 years · compounded
▲ 57%
EBITDA CAGR growth
1 year
▲ 107%
3 years · compounded
▲ 27%
5 years · compounded
▲ 20%

Revenue has grown at a compounded annual rate (CAGR) of 57% over five years. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Violet Medi-Pharma Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.04 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹54,750••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Violet Medi-Pharma Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin0.8%••••••••••••••••
Net Profit Margin0.4%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Violet Medi-Pharma are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Violet Medi-Pharma Private Limited

Violet Medi-Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Biostar Pharmaceuticals Private Limited₹1.28 Cr (FY 2025)••••••••0.0%••••Pune, Maharashtra, India
Sab Lifecare Private Limited₹1.28 Cr (FY 2025)••••••••6.0%••••Nagpur, Maharashtra, India
Orchid Biomedical Systems Private Limited₹1.28 Cr (FY 2025)••••••••1020928.0%••••Thane, Maharashtra, India
Infinite Education & Healthcare Private Limited₹1.28 Cr (FY 2025)••••••••14.0%••••Sahibabad, Uttar Pradesh, India
Diya Healthcare Private Limited₹1.28 Cr (FY 2024)••••••••-24.0%••••Chandigarh, India
Violet Medi-Pharma Private Limited this company₹1.27 Cr (FY 2022)••••••••••••Mumbai, Maharashtra, India
Aarka Medicare Private Limited₹1.27 Cr (FY 2025)••••••••-71.0%••••Hyderabad, Telangana, India
Geomatrix Healthcare Private Limited₹1.27 Cr (FY 2025)••••••••-26.0%••••Lower Parel West, Maharashtra, India
Safe Associates Private Limited₹1.27 Cr (FY 2025)••••••••46.0%••••Bhubaneswar, Odisha, India
Viovas Pharma Private Limited₹1.27 Cr (FY 2025)••••••••••••New Delhi, Delhi, India
Minogenix Pharma Private Limited₹1.27 Cr (FY 2025)••••••••1.0%••••Chennai, Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Violet Medi-Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Violet Medi-Pharma Private Limited

Violet Medi-Pharma Private Limited is audited by B B JAIN & ASSOCIATES for the financial year 2017.

NameStatusAppointment DateCessation Date
B B JAIN & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Violet Medi-Pharma Private Limited

Violet Medi-Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Hitesh Sampat RanawatDirector21 Aug 201511 Years 1 MonthsCurrent
Sampat Surajmal RanawatDirector15 Jul 201610 Years 2 MonthsCurrent

Ownership and Shareholding of Violet Medi-Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Violet Medi-Pharma Private Limited

Violet Medi-Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Violet Medi-Pharma Private Limited

Employment history and EPFO contributions of people linked to Violet Medi-Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Violet Medi-Pharma Private Limited

Violet Medi-Pharma Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Sampat Surajmal Ranawat ceased to be Additional Director on 30 Sep 2016.

AGM
Violet Medi-Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Violet Medi-Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai I.
Ceased
Sampat Surajmal Ranawat ceased to be Additional Director.
Ceased
Mahendra Shashikant Tandel ceased to be Director.
Ceased
Santoshkumar Govindrao Gaikwad ceased to be Director.
Appointed
Sampat Surajmal Ranawat was appointed as Director.
Appointed
Hitesh Sampat Ranawat was appointed as Director.
Incorporation
21 Aug 2015
Violet Medi-Pharma Private Limited was registered on 21 Aug 2015 with Roc Mumbai I & aged 11 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Violet Medi-Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Violet Medi-Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Violet Medi-Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Violet Medi-Pharma Private Limited

Violet Medi-Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAFCV2125H1ZGMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Violet Medi-Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Violet Medi-Pharma Private Limited

Violet Medi-Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 August 2015 (11+ years old) and is registered under CIN U74120MH2015PTC267648.

Violet Medi-Pharma reported revenue of ₹1.27 Cr for FY 2022.

Violet Medi-Pharma has 2 current directors:

Violet Medi-Pharma reported a net profit of ₹54,750 (net margin 0.4%) and EBITDA of ₹1.04 Lakh (EBITDA margin 0.8%) for FY 2022, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Violet Medi-Pharma is -18% over three years and 57% over five years. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Violet Medi-Pharma is 27AAFCV2125H1ZG, registered in Maharashtra.

The CIN (Corporate Identification Number) of Violet Medi-Pharma is U74120MH2015PTC267648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Violet Medi-Pharma has 1 court case on record: 1 filed against it.

Violet Medi-Pharma was incorporated on 21 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Violet Medi-Pharma by revenue are Biostar Pharmaceuticals Private Limited, Sab Lifecare Private Limited, Orchid Biomedical Systems Private Limited, Infinite Education & Healthcare Private Limited, Diya Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Sampat Surajmal Ranawat ceased to be Additional Director on 30 Sep 2016. Mahendra Shashikant Tandel ceased to be Director on 16 Jul 2016. Santoshkumar Govindrao Gaikwad ceased to be Director on 16 Jul 2016. Violet Medi-Pharma has 5 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available